Renal Denervation for Uncontrolled Hypertension (7.01.136)
Summary
Blue Shield of California's medical policy 7.01.136 now considers radiofrequency ablation of the renal sympathetic nerves medically necessary for individuals whose blood pressure remains above 130/80 mmHg despite use of 3 or more antihypertensive medications from 3 classes at maximally tolerated doses, or with intolerance to antihypertensive medications whose blood pressure remains uncontrolled despite attempting lifestyle modifications. The policy also considers ultrasound ablation of the renal sympathetic nerves medically necessary under the same criteria. Before this version, radiofrequency ablation was considered investigational for the treatment of uncontrolled hypertension, and the effective date of this version is March 1, 2026.
Get alerts when payers change rules like this one
We check Blue Shield of California and other payers every day and email you when a change matches your specialty and state.